This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Badal, V.
Right arrow Articles by Bernard, H.-U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Badal, V.
Right arrow Articles by Bernard, H.-U.

 Previous Article  |  Next Article 

Journal of Virology, June 2003, p. 6227-6234, Vol. 77, No. 11
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.11.6227-6234.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

CpG Methylation of Human Papillomavirus Type 16 DNA in Cervical Cancer Cell Lines and in Clinical Specimens: Genomic Hypomethylation Correlates with Carcinogenic Progression

Vinay Badal,1 Linda S. H. Chuang,1 Eileen Hwee-Hong Tan,1 Sushma Badal,2 Luisa L. Villa,3 Cosette M. Wheeler,4 Benjamin F. L. Li,1 and Hans-Ulrich Bernard2,5*

Laboratory for DNA Repair and DNA Methylation in Chemical Carcinogenesis,1 Laboratory for Papillomavirus Biology, Institute of MolecularCell Biology, Singapore 117609, Singapore,2 Department of Molecular Biology and Biochemistry, University of California—Irvine, Irvine, California 92697-3900,5 Ludwig Institute for Cancer Research, Sao Paulo, Brazil,3 Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, New Mexico 87131-62764

Received 29 January 2003/ Accepted 14 March 2003

Infection with genital human papillomaviruses (HPVs) is the primary cause of cervical cancer. The infection is widespread, and little is known about the secondary factors associated with progression from subclinical infection to invasive carcinoma. Here we report that HPV genomes are efficiently targeted in vivo by CpG methylation, a well-known mechanism of transcriptional repression. Indeed, it has been shown previously that in vitro-methylated HPV type 16 (HPV-16) DNA is transcriptionally repressed after transfection into cell cultures. By using a scan with the restriction enzyme McrBC, we observed a conserved profile of CpG hyper- and hypomethylation throughout the HPV-16 genomes of the tumor-derived cell lines SiHa and CaSki. Methylation is particularly high in genomic segments overlying the late genes, while the long control region (LCR) and the oncogenes are unmethylated in the single HPV-16 copy in SiHa cells. In 81 patients from two different cohorts, the LCR and the E6 gene of HPV-16 DNA were found to be hypermethylated in 52% of asymptomatic smears, 21.7% of precursor lesions, and 6.1% of invasive carcinomas. This suggests that neoplastic transformation may be suppressed by CpG methylation, while demethylation occurs as the cause of or concomitant with neoplastic progression. These prevalences of hyper- and hypomethylation also indicate that CpG methylation plays an important role in the papillomavirus life cycle, which takes place in asymptomatic infections and precursor lesions but not in carcinomas. Bisulfite modification revealed that in most of the HPV-16 genomes of CaSki cells and of asymptomatic patients, all 11 CpG dinucleotides that overlap with the enhancer and the promoter were methylated, while in SiHa cells and cervical lesions, the same 11 or a subset of CpGs remained unmethylated. Our report introduces papillomaviruses as models to study the mechanism of CpG methylation, opens research on the importance of this mechanism during the viral life cycle, and provides a marker relevant for the etiology and diagnosis of cervical cancer.


* Corresponding author. Mailing address: Department of Molecular Biology and Biochemistry, University of California—Irvine, Irvine, CA 92697-3900. Phone: (949) 824-5162. Fax: (949) 824-8551. E-mail: hbernard{at}uci.edu.


Journal of Virology, June 2003, p. 6227-6234, Vol. 77, No. 11
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.11.6227-6234.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Flatley, J. E., McNeir, K., Balasubramani, L., Tidy, J., Stuart, E. L., Young, T. A., Powers, H. J. (2009). Folate Status and Aberrant DNA Methylation Are Associated With HPV Infection and Cervical Pathogenesis. Cancer Epidemiol. Biomarkers Prev. 18: 2782-2789 [Abstract] [Full Text]  
  • Sigurdsson, M. I., Smith, A. V., Bjornsson, H. T., Jonsson, J. J. (2009). HapMap methylation-associated SNPs, markers of germline DNA methylation, positively correlate with regional levels of human meiotic recombination. Genome Res 19: 581-589 [Abstract] [Full Text]  
  • Hoelzer, K., Shackelton, L. A., Parrish, C. R. (2008). Presence and role of cytosine methylation in DNA viruses of animals. Nucleic Acids Res 36: 2825-2837 [Abstract] [Full Text]  
  • Furniss, C. S., Marsit, C. J., Houseman, E. A., Eddy, K., Kelsey, K. T. (2008). Line Region Hypomethylation Is Associated with Lifestyle and Differs by Human Papillomavirus Status in Head and Neck Squamous Cell Carcinomas. Cancer Epidemiol. Biomarkers Prev. 17: 966-971 [Abstract] [Full Text]  
  • Sanchez, I. E., Dellarole, M., Gaston, K., de Prat Gay, G. (2008). Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res 36: 756-769 [Abstract] [Full Text]  
  • De-Castro Arce, J., Gockel-Krzikalla, E., Rosl, F. (2007). Retinoic Acid Receptor beta Silences Human Papillomavirus-18 Oncogene Expression by Induction of de Novo Methylation and Heterochromatinization of the Viral Control Region. J. Biol. Chem. 282: 28520-28529 [Abstract] [Full Text]  
  • Ting Hsiung, D., Marsit, C. J., Houseman, E. A., Eddy, K., Furniss, C. S., McClean, M. D., Kelsey, K. T. (2007). Global DNA Methylation Level in Whole Blood as a Biomarker in Head and Neck Squamous Cell Carcinoma. Cancer Epidemiol. Biomarkers Prev. 16: 108-114 [Abstract] [Full Text]  
  • Kalantari, M., Calleja-Macias, I. E., Tewari, D., Hagmar, B., Lie, K., Barrera-Saldana, H. A., Wiley, D. J., Bernard, H.-U. (2004). Conserved Methylation Patterns of Human Papillomavirus Type 16 DNA in Asymptomatic Infection and Cervical Neoplasia. J. Virol. 78: 12762-12772 [Abstract] [Full Text]  
  • Van Tine, B. A., Kappes, J. C., Banerjee, N. S., Knops, J., Lai, L., Steenbergen, R. D. M., Meijer, C. L. J. M., Snijders, P. J. F., Chatis, P., Broker, T. R., Moen, P. T. Jr., Chow, L. T. (2004). Clonal Selection for Transcriptionally Active Viral Oncogenes during Progression to Cancer. J. Virol. 78: 11172-11186 [Abstract] [Full Text]  
  • Bernard, H.-U. (2004). Established and potential strategies against papillomavirus infections. J Antimicrob Chemother 53: 137-139 [Abstract] [Full Text]  
  • Kim, K., Garner-Hamrick, P. A., Fisher, C., Lee, D., Lambert, P. F. (2003). Methylation Patterns of Papillomavirus DNA, Its Influence on E2 Function, and Implications in Viral Infection. J. Virol. 77: 12450-12459 [Abstract] [Full Text]